Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7517
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic ; volume:19 ; number:1 ; day:29 ; month:6 ; year:2022 ; pages:1-6 ; date:12.2022
Harm reduction journal ; 19, Heft 1 (29.6.2022), 1-6, 12.2022
- Urheber
-
Dadiomov, David
Bolshakova, Maria
Mikhaeilyan, Melania
Trotzky-Sirr, Rebecca
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12954-022-00651-3
- URN
-
urn:nbn:de:101:1-2022082020480844025761
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dadiomov, David
- Bolshakova, Maria
- Mikhaeilyan, Melania
- Trotzky-Sirr, Rebecca
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Naloxone availability in independent community pharmacies in Georgia, 2019
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Naloxone should remain the appropriate antidote to treat opioid overdose
Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Preventing opioid overdose with peer-administered naloxone: findings from a rural state
Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Naloxone availability in independent community pharmacies in Georgia, 2019
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Naloxone should remain the appropriate antidote to treat opioid overdose
Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Preventing opioid overdose with peer-administered naloxone: findings from a rural state
Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Naloxone availability in independent community pharmacies in Georgia, 2019
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Naloxone should remain the appropriate antidote to treat opioid overdose
Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Preventing opioid overdose with peer-administered naloxone: findings from a rural state